Abstract
Oral verrucous carcinoma is considered to be a histological subtype of oral squamous cell carcinoma, which generally follows a more indolent clinical course. It presents a specific clinical challenge in that it can be difficult to reach a definitive diagnosis and harbours the potential to transform into the more aggressive squamous cell carcinoma. In this chapter, we will discuss the background of this disease and the potential and previous role of next-generation sequencing (NGS) in head and neck cancer. The use of low coverage NGS to produce copy number variation (CNV) data and demonstrate how different computational methods can be applied to that data to analyse patterns and identify targets of interest. The application of NGS to detect and determine the prevalence of human papillomavirus in this disease will also be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ferlay J, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.
Scully C, Bagan JV. Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis. 2009;15(6):388–99.
Bagan J, Sarrion G, Jimenez Y. Oral cancer: clinical features. Oral Oncol. 2010;46(6):414–7.
Kademani D. Oral cancer. Mayo Clin Proc. 2007;82(7):878–87.
Cabay RJ, Morton Jr TH, Epstein JB. Proliferative verrucous leukoplakia and its progression to oral carcinoma: a review of the literature. J Oral Pathol Med. 2007;36(5):255–61.
Zhu LK, et al. A clinicopathological study on verrucous hyperplasia and verrucous carcinoma of the oral mucosa. J Oral Pathol Med. 2012;41(2):131–5.
Califano J, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996;56(11):2488–92.
Thomson PJ, et al. Epithelial cell proliferative activity and oral cancer progression. Cell Prolif. 2002;35:110–20.
Kushner J, Bradley G, Jordan RCK. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth. J Pathol. 1997;183(4):418–23.
Gonzalez-Moles MA, et al. Suprabasal expression of Ki-67 antigen as a marker for the presence and severity of oral epithelial dysplasia. Head Neck. 2000;22(7):658–61.
Shear M, Pindborg JJ. Verrucous hyperplasia of the oral-mucosa. Cancer. 1980;46(8):1855–62.
Wang YP, et al. Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications. J Oral Pathol Med. 2009;38(8):651–6.
Hsue SS, et al. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med. 2007;36(1):25–9.
Ho PS, et al. Malignant transformation of oral potentially malignant disorders in males: a retrospective cohort study. BMC Cancer. 2009;9:260.
Ackerman LV. Verrucous carcinoma of the oral cavity. Surgery. 1948;23(4):670–8.
Barnes L, Eveson JW, Reichart P, Sidransky D. WHO classification of tumours, pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005. p. 174–5.
Pentenero M, et al. Distinctive chromosomal instability patterns in oral verrucous and squamous cell carcinomas detected by high-resolution DNA flow cytometry. Cancer. 2011;117(22):5052–7.
Ray JG, et al. Oral verrucous carcinoma – a misnomer? Immunohistochemistry based comparative study of two cases. BMJ Case Rep. 2011;2011.
Bagan J, et al. Proliferative verrucous leukoplakia: a concise update. Oral Dis. 2010;16(4):328–32.
Alkan A, et al. Oral verrucous carcinoma: a study of 12 cases. Eur J Dent. 2010;4(2):202–7.
Chung CH, et al. Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan. J Oral Pathol Med. 2005;34(8):460–6.
Stokes A, et al. Human papillomavirus detection in dysplastic and malignant oral verrucous lesions. J Clin Pathol. 2012;65(3):283–6.
Syrjänen KJ, Stina SS, Syrjänen M. Papillomavirus infections in human pathology. New York: Wiley; 2000.
Klieb HB, Raphael SJ. Comparative study of the expression of p53, Ki67, E-cadherin and MMP-1 in verrucous hyperplasia and verrucous carcinoma of the oral cavity. Head Neck Pathol. 2007;1(2):118–22.
Haimovich AD. Methods, challenges, and promise of next-generation sequencing in cancer biology. Yale J Biol Med. 2011;84(4):439–46.
Agrawal N, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011;333(6046):1154–7.
Stransky N, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011;333(6046):1157–60.
Lui VWY, et al. Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov. 2013;3(7):761–9.
Conway C, et al. Next-generation sequencing for simultaneous determination of human papillomavirus load, subtype, and associated genomic copy number changes in tumors. J Mol Diagn. 2012;14(2):104–11.
Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet. 2010;11(10):685–96.
Wood HM, et al. Using next-generation sequencing for high resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens. Nucleic Acids Res. 2010;38(14):e151.
Woolgar JA, Triantafyllou A. Pitfalls and procedures in the histopathological diagnosis of oral and oropharyngeal squamous cell carcinoma and a review of the role of pathology in prognosis. Oral Oncol. 2009;45(4–5):361–85.
Eversole LR, Papanicolaou SJ. Papillary and verrucous lesions of oral mucous membranes. J Oral Med. 1983;38(1):3–13.
Xie C, Tammi MT. CNV-seq, a new method to detect copy number variation using high-throughput sequencing. BMC Bioinformatics. 2009;10:80.
Hayes JL, et al. Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation. Genomics. 2013;102(3):174–81.
Chiang DY, et al. High-resolution mapping of copy-number alterations with massively parallel sequencing. Nat Methods. 2009;6(1):99–103.
Gusnanto A, et al. Correcting for cancer genome size and tumour cell content enables better estimation of copy number alterations from next-generation sequence data. Bioinformatics. 2012;28(1):40–7.
Nguyen DQ, Webber C, Ponting CP. Bias of selection on human copy-number variants. PLoS Genet. 2006;2(2):198–207.
Sharp AJ, et al. Segmental duplications and copy-number variation in the human genome. Am J Hum Genet. 2005;77(1):78–88.
Poh CF, et al. A high frequency of allelic loss in oral verrucous lesions may explain malignant risk. Lab Invest. 2001;81(4):629–34.
Mohapatra G, et al. Glioma test array for use with formalin-fixed, paraffin-embedded tissue - Array comparative genomic hybridization correlates with loss of heterozygosity and fluorescence in situ hybridization. J Mol Diagn. 2006;8(2):268–76.
Mermel CH, et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12(4):R41.
Bass AJ, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet. 2009;41(11):1238–42.
Firestein R, et al. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature. 2008;455(7212):547–51.
Lin WM, et al. Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Res. 2008;68(3):664–73.
Etemadmoghadam D, et al. Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas. Clin Cancer Res. 2009;15(4):1417–27.
Weir BA, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature. 2007;450(7171):893–8.
Chiang DY, et al. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res. 2008;68(16):6779–88.
Northcott PA, et al. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet. 2009;41(4):465–72.
Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics (vol 5, pg 997, 2006). Nat Rev Drug Discov. 2007;6(3):249.
Li H, et al. SUZ12 Promotes Human Epithelial Ovarian Cancer by Suppressing Apoptosis via Silencing HRK. Mol Cancer Res. 2012;10(11):1462–72.
Berx G, et al. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat. 1998;12(4):226–37.
Onder TT, et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008;68(10):3645–54.
Vermeulen S, et al. Regulation of the invasion suppressor function of the cadherin/catenin complex. Pathol Res Pract. 1996;192(7):694–707.
Tamura T, et al. Minichromosome maintenance-7 and geminin are reliable prognostic markers in patients with oral squamous cell carcinoma: immunohistochemical study. J Oral Pathol Med. 2010;39(4):328–34.
Chin D, et al. Novel markers for poor prognosis in head and neck cancer. Int J Cancer. 2005;113(5):789–97.
Chen YJ, et al. Genome-wide profiling of oral squamous cell carcinoma. J Pathol. 2004;204(3):326–32.
Samman M, et al. Next-generation sequencing analysis for detecting human papillomavirus in oral verrucous carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118(1):117–25. e1.
Coughlin CR, Scharer GH, Shaikh TH. Clinical impact of copy number variation analysis using high-resolution microarray technologies: advantages, limitations and concerns. Genome Med. 2012;4:80.
Ferrer I, et al. Effects of formalin fixation, paraffin embedding, and time of storage on DNA preservation in brain tissue: a BrainNet Europe study. Brain Pathol. 2007;17(3):297–303.
Bhattacharya A, et al. Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis. Clin Cancer Res. 2011;17(22):7024–34.
Smeets SJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer. 2007;121(11):2465–72.
Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982–1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91(6):622–35.
Brady RC, Bernstein DI. Treatment of herpes simplex virus infections. Antiviral Res. 2004;61(2):73–81.
Everly D et al. 2012. Herpesviruses and cancer. In:Robertson ES. Cancer associated viruses. Springer-Verlag New York, pp. 133–167.
Ferreira DC, et al. Identification of herpesviruses types 1 to 8 and human papillomavirus in acute apical abscesses. J Endod. 2011;37(1):10–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Samman, M., Sethi, N. (2015). Using Next-Generation Sequencing to Reveal Patterns of Chromosomal Alterations in Oral Verrucous Lesions. In: Wu, W., Choudhry, H. (eds) Next Generation Sequencing in Cancer Research, Volume 2. Springer, Cham. https://doi.org/10.1007/978-3-319-15811-2_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-15811-2_19
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15810-5
Online ISBN: 978-3-319-15811-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)